<?xml version="1.0" encoding="UTF-8"?>
<p id="par0210">Ivermectin is a broad spectrum anti-parasitic drug, but it has also shown anti-viral activity in vitro with its confirmed ability to inhibit integrase protein (IN) nuclear import and HIV-1 replication. It has also shown its ability to inhibit nuclear import of host and viral proteins [
 <xref rid="bib0355" ref-type="bibr">71</xref>,
 <xref rid="bib0360" ref-type="bibr">72</xref>]. A recent in vitro study tested the antiviral activity of ivermectin against SARS-CoV-2 [
 <xref rid="bib0360" ref-type="bibr">72</xref>]. Ivermectin treatment resulted in 99.8 % reduction in all viral material within 48 h compared to control samples. These results made the authors propose Ivermectin as a possible treatment for COVID-19 since it’s an FDA approved drug with a known safety profile.
</p>
